- Home
- DAVA vs SRTA Comparison
DAVA vs SRTA Comparison
Compare DAVA & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAVA
- SRTA
- Stock Information
- Founded
- DAVA 2000
- SRTA 2014
- Country
- DAVA United Kingdom
- SRTA United States
- Employees
- DAVA N/A
- SRTA N/A
- Industry
- DAVA EDP Services
- SRTA
- Sector
- DAVA Technology
- SRTA
- Exchange
- DAVA Nasdaq
- SRTA Nasdaq
- Market Cap
- DAVA 509.6M
- SRTA 438.4M
- IPO Year
- DAVA 2018
- SRTA N/A
- Fundamental
- Price
- DAVA $9.48
- SRTA $5.03
- Analyst Decision
- DAVA Buy
- SRTA Strong Buy
- Analyst Count
- DAVA 9
- SRTA 1
- Target Price
- DAVA $22.89
- SRTA $7.25
- AVG Volume (30 Days)
- DAVA 952.7K
- SRTA 694.9K
- Earning Date
- DAVA 11-11-2025
- SRTA 11-10-2025
- Dividend Yield
- DAVA N/A
- SRTA N/A
- EPS Growth
- DAVA 24.14
- SRTA N/A
- EPS
- DAVA 0.49
- SRTA N/A
- Revenue
- DAVA $1,058,028,497.00
- SRTA $254,341,000.00
- Revenue This Year
- DAVA N/A
- SRTA N/A
- Revenue Next Year
- DAVA $3.81
- SRTA $28.16
- P/E Ratio
- DAVA $19.18
- SRTA N/A
- Revenue Growth
- DAVA 4.25
- SRTA 6.70
- 52 Week Low
- DAVA $8.17
- SRTA $3.85
- 52 Week High
- DAVA $34.94
- SRTA $6.02
- Technical
- Relative Strength Index (RSI)
- DAVA 50.31
- SRTA N/A
- Support Level
- DAVA $8.55
- SRTA N/A
- Resistance Level
- DAVA $9.03
- SRTA N/A
- Average True Range (ATR)
- DAVA 0.37
- SRTA 0.00
- MACD
- DAVA 0.15
- SRTA 0.00
- Stochastic Oscillator
- DAVA 84.31
- SRTA 0.00
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.
About SRTA Strata Critical Medical Inc. Class A Common Stock
Strata Critical Medical Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs.